Fibroblast Growth Factor-23 Secreting Tumour Induced Osteomalacia (original) (raw)

Lessons learnt from delayed diagnosis of FGF-23-producing tumour-induced osteomalacia and post-operative hungry bone syndrome

terry diamond

Bone reports, 2020

View PDFchevron_right

Oncogenic osteomalacia: Diagnostic importance of fibroblast growth factor 23 and F-18 fluorodeoxyglucose PET/CT SCAN for the diagnosis and follow-up in one case

H. Gil

Bone, 2005

View PDFchevron_right

Sensitivity of Fibroblast Growth Factor 23 Measurements in Tumor-Induced Osteomalacia

Munro Peacock

The Journal of Clinical Endocrinology & Metabolism, 2006

View PDFchevron_right

Diagnosis and Management of Tumor-induced Osteomalacia: Perspectives From Clinical Experience

Julia Charles

Journal of the Endocrine Society, 2021

View PDFchevron_right

Oncogenic osteomalacia illustrating the effect of fibroblast growth factor 23 on phosphate homeostasis

Jaak Billen

Clinical kidney journal, 2012

View PDFchevron_right

Localization of Oncogenic Osteomalacia by Systemic Venous Sampling of Fibroblast Growth Factor 23

Kelly Lim

Yonsei medical journal, 2017

View PDFchevron_right

Tumor-induced osteomalacia

Pablo Florenzano

Bone Reports, 2017

View PDFchevron_right

Tumor-induced osteomalacia: a case report

Jacob Vahaneyil

Arquivos Brasileiros de Endocrinologia & Metabologia, 2009

View PDFchevron_right

Tumor(s) Induced Osteomalacia—A Curious Case of Double Trouble

Sadishkumar Kamalanathan

The Journal of Clinical Endocrinology & Metabolism, 2014

View PDFchevron_right

Tumor-induced osteomalacia: The tumor may stay hidden!

Roland Hustinx

Clinical Biochemistry, 2011

View PDFchevron_right

Tumor localization and biochemical response to cure in tumor‐induced osteomalacia

Richard Chang

Journal of Bone and Mineral Research, 2013

View PDFchevron_right

Oncogenic hypophosphataemic osteomalacia: biomarker roles of fibroblast growth factor 23, 1,25-dihydroxyvitamin D3 and lymphatic vessel endothelial hyaluronan receptor 1

James Teh

European Journal of Endocrinology, 2008

View PDFchevron_right

Resolution of severe, adolescent-onset hypophosphatemic rickets following resection of an FGF-23-producing tumour of the distal ulna

Guido Filler

Bone, 2004

View PDFchevron_right

Fibroblast Growth Factor 23: A New Clinical Marker for Oncogenic Osteomalacia

Rebecca Mason

The Journal of Clinical Endocrinology & Metabolism, 2003

View PDFchevron_right

Advanced prostate cancer as a cause of oncogenic osteomalacia: an underdiagnosed condition

Milena Mak, Regina Martin

Supportive Care in Cancer, 2012

View PDFchevron_right

FGF23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting

anurag gupta

Journal of Clinical Investigation, 2003

View PDFchevron_right

Tumor producing fibroblast growth factor 23 localized by two-staged venous sampling

P. Dijkhuizen, Hans Boer

European Journal of Endocrinology, 2008

View PDFchevron_right

Fibroblast Growth Factor 23 is Elevated in Tenofovir-Related Hypophosphatemia

María Soledad Báez

View PDFchevron_right

Bone scintigraphic patterns in patients of tumor induced osteomalacia

Jaya Shukla

Indian Journal of Nuclear Medicine, 2013

View PDFchevron_right

Tumor-induced osteomalacia—a diagnostic dilemma for an orthopedic surgeon

Deep Sharma

European Orthopaedics and Traumatology, 2013

View PDFchevron_right

Oncogenic osteomalacia: loss of hypophosphatemia might be the key to avoid misdiagnosis

Gláucia Mazeto

2012

View PDFchevron_right

Fibroblast growth factor 23–secreting pancreaticobiliary malignancy

Valerie Barta

Journal of Onco-Nephrology, 2018

View PDFchevron_right

Needle(S) in the Haystack - Synchronous Multifocal Tumor Induced Osteomalacia

VENKATESH RANGARAJAN

The Journal of clinical endocrinology and metabolism, 2015

View PDFchevron_right

Improving Diagnosis of Tumor-Induced Osteomalacia With Gallium-68 DOTATATE PET/CT

Rodney Hicks

The Journal of Clinical Endocrinology & Metabolism, 2013

View PDFchevron_right

An intracranial mass causing tumor-induced osteomalacia (TIO): Rapid and complete resolution of severe osteoporosis after surgical resection

Juan Colazo

Radiology Case Reports

View PDFchevron_right

Elevated FGF23 in a patient with hypophosphatemic osteomalacia associated with neurofibromatosis type 1

Priyanka Kushwaha

Bone, 2019

View PDFchevron_right

Tumor-induced osteomalacia: experience from a South American academic center

Pablo Florenzano

Osteoporosis International, 2017

View PDFchevron_right

Oncogenic osteomalacia: A reversible metabolic bone disorder

Dineshkumar Dhanwal

Indian Journal of Orthopaedics, 2010

View PDFchevron_right

Tumor-induced osteomalacia: experience from three tertiary care centers in India

Manoj Chadha

Endocrine Connections

View PDFchevron_right

Identifying the culprit lesion in tumor induced hypophosphatemia, the solution of a clinical enigma

Neveen Hamdy

Endocrine, 2016

View PDFchevron_right

Targeted FGFR Blockade for the Treatment of Tumor-Induced Osteomalacia

Pablo Florenzano

New England Journal of Medicine

View PDFchevron_right